Related Experiment Videos

GM-CSF in the treatment of Felty syndrome

G Joseph¹, D H Neustadt, J Hamm

¹Divsion of Hematology/Oncology, James Graham Brown Cancer Center.

American Journal of Hematology

|May 1, 1991

Abstract:

Many therapeutic agents have been tried with variable success in the treatment of Felty neutropenia, but the reports are anecdotal. We now describe the second trial of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF), in a splenectomized, infected patient with Felty syndrome.

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Effects of the microbicide ceragenin CSA-13 on and properties of Bacillus subtilis spores prepared on two very different media.

Journal of applied microbiology·2019

Metabolic tumour volume is prognostic in patients with non-small-cell lung cancer treated with stereotactic ablative radiotherapy.

Current oncology (Toronto, Ont.)·2019

Stereotactic Body Radiotherapy for Small Unresectable Hepatocellular Carcinomas.

Clinical oncology (Royal College of Radiologists (Great Britain))·2019

Efficacy and tolerability of trabectedin in elderly patients with sarcoma: subgroup analysis from a phase III, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Determination of Total Biotin by Liquid Chromatography Coupled with Immunoaffinity Column Cleanup Extraction: Multilaboratory Testing, Final Action 2016.02.

Journal of AOAC International·2017

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer.

British journal of cancer·2017

See all related articles